Tasimelteon

产品说明书

Print
Chemical Structure| 609799-22-6 同义名 : BMS-214778; VEC-162; BMS214778, BMS-214778, BMS 214778, VEC162, VEC-162, VEC 162, Tasimelteon, Hetlioz
CAS号 : 609799-22-6
货号 : A125322
分子式 : C15H19NO2
纯度 : 98%
分子量 : 245.32
MDL号 : MFCD09033789
存储条件:

Pure form Sealed in dry, 2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Tasimelteon (BMS-214778) is a dual melatonin receptor agonist (DMRA) with 2.1-4.4 times greater affinity for the MT2 receptor than the MT1 receptor, making it a potential circadian regulator for Non-24-Hour Sleep-Wake Disorder (Non-24) [1][2].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00548340 Primary Insomnia Phase 3 Completed - -
NCT00548340 - Completed - -
NCT01402076 Healthy Volunteers Phase 1 Completed - United States, Missouri ... 展开 >> Bio-Kinetic Clinical Applications Springfield, Missouri, United States, 65802 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

4.08mL

0.82mL

0.41mL

20.38mL

4.08mL

2.04mL

40.76mL

8.15mL

4.08mL

参考文献

[1]Christian Lavedan, et al. Tasimelteon: a selective and unique receptor binding profile. Neuropharmacology. 2015 Apr;91:142-7.

[2]Chakkalakal SA, et al. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. J Bone Miner Res. 2016 Sep;31(9):1666-75.